InsidersTradesSigma
Discover the complete record of transactions filed by Gaal Lubor, Director. Officer active across 1 company, notably Timber Pharmaceuticals, Inc.. Aggregated, 1 disclosures have been published. History available since 15 April 2022. The latest transaction was disclosed on 15 April 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Lubor Gaal is a Board Member at Timber Pharmaceuticals, Inc. He participates in the governance of the company and contributes to strategic decision-making. His expertise in the pharmaceutical field is an asset for Timber Pharmaceuticals, which focuses on developing innovative treatments. As a board member, Lubor is committed to promoting best practices in corporate governance.